Department of Hepatobiliary Surgery
Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen
肝胆外科 · Hepatobiliary and Pancreatic Surgery
This department focuses on the diagnosis and treatment of tumors affecting the liver, bile ducts, pancreas, and related areas. Care includes minimally invasive surgery, targeted therapy, immunotherapy, and radiation. The team performs complex procedures such as resections for large liver tumors, difficult bile duct cancers, and pancreatic cancers involving blood vessels. Techniques include fluorescence laparoscopy, intraoperative ultrasound, microwave ablation, and single-port laparoscopic surgery. The department also offers multidisciplinary team (MDT) remote consultations and post-operative care like chemotherapy and radiofrequency ablation to manage recurrence. According to the hospital, surgical success rates exceed 95% for hepatobiliary and pancreatic cases.
What the department treats
- Surgery for primary liver, bile duct, and pancreatic tumors
- Treatment for liver metastases and gastrointestinal tumors
- Fluorescence laparoscopic liver resection
- Intraoperative ultrasound and microwave ablation
- Complex bile duct and pancreatic tumor resection with vascular reconstruction
- Multidisciplinary team (MDT) remote consultation
Key facts
- The department has 47 open beds and a staff of 24, including 8 doctors and 16 nurses.
- Reported surgical success rate is over 98% for major liver tumor resections, with mortality under 1%.
- Reported surgical success rate is over 95% for bile duct and pancreatic surgeries, with mortality under 3%.
As described by the hospital.
Team
19 doctors listed, including 5 chief physicians. Its chief physicians have 37 first- or senior-author papers on PubMed since 2016.
| Chief physician | Clinical focus | Key papers since 2016 |
|---|---|---|
| Dr. Xu Che 车旭 | Diagnosis and minimally invasive surgery for pancreatic, hepatobiliary, liver metastasis, gastrointestinal, pancreatic neuroendocrine, and retroperitoneal tumors. Focuses on comprehensive immunotherapy and translational research. | 32 |
| Dr. Xinyu Bi 毕新宇 | Surgical treatment of liver cancer, hilar cholangiocarcinoma, periampullary cancer, gallbladder cancer, cholangiocarcinoma, and colorectal liver metastases. | 5 |
| Dr. Jianjun Zhao 赵建军 | Surgical and comprehensive treatment of primary and metastatic liver cancer, biliary tract tumors, gastrointestinal stromal tumors, neuroendocrine tumors, and retroperitoneal tumors. Focuses on nanoknife ablation for difficult hepatobiliary tumors and combined resection with ablation for complex cases. | 0 |
| Dr. Zhiyu Li 李智宇 | Surgical and comprehensive treatment of primary liver, bile duct, gallbladder, and pancreatic tumors; liver metastases from gastrointestinal cancers; neuroendocrine tumors; and retroperitoneal tumors. | 0 |
Associate chief physicians
- Dr. Xiaozhun Huang黄小准
- Dr. Lin Xu徐林
We are an independent coordination service, not part of this hospital. Team data comes from public doctor-listing platforms; publication counts come from PubMed, matched by full name and affiliation, and doctors with very common names are checked by hand before their papers are shown. How we build this directory.
Not sure which specialist is right?
Send your records. We find a specialist in the right field to review your case and write a treatment plan with a cost estimate.
Get a specialist opinion